Literature DB >> 8613677

Might intrinsic radioresistance of human tumour cells be induced by radiation?

P Lambin1, E P Malaise, M C Joiner.   

Abstract

Survival measurements were made on six human tumour cell lines in vitro after irradiation with single doses of X rays. Doses up to 5 Gy were used giving surviving fractions down to 20%, but the majority of the measurements were made at doses < 1 Gy. These six cell lines have very different intrinsic radiosensitivities: HT29, Be11, and RT112 are radioresistant with surviving fractions at 2 Gy (SF2) between 60 and 74%, while MeWo, SW48, and HX142 are radiosensitive (SF2 = 3-29%). For all the cell lines, response over the dose range 2-5 Gy showed a good fit to a Linear-Quadratic (LQ) model. However, HT29, Be11, and RT112 cells showed a significant increase in X-ray radiosensitivity at doses below < 1 Gy compared with the prediction extrapolated from a LQ model fitted to the data at higher doses. The LQ model also slightly underpredicted the effect of low-dose X rays in MeWo cells, but the response of SW48 and HX142 cells was well described by the LQ model at all doses, with no evidence of increased low-dose effectiveness. The most plausible explanation for this phenomenon is that it reflects an induced radioresistance so that low doses of X-rays in vitro are more effective per Gy than higher doses, because only at higher doses is there sufficient damage to trigger repair systems or other radioprotective mechanisms. It follows that variation in the amount of inducible radioresistance might explain, in part, differences in intrinsic radiosensitivity above > 1 Gy between cell lines: cells would be intrinsically radiosensitive because they have a diminished inducible response.

Entities:  

Mesh:

Year:  1996        PMID: 8613677     DOI: 10.1080/095530096145832

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  11 in total

1.  Effects of G2-checkpoint dynamics on low-dose hyper-radiosensitivity.

Authors:  Oluwole Olobatuyi; Gerda de Vries; Thomas Hillen
Journal:  J Math Biol       Date:  2018-04-20       Impact factor: 2.259

2.  Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study.

Authors:  Mario Balducci; Silvia Chiesa; Barbara Diletto; Giuseppe Roberto D'Agostino; Annunziato Mangiola; Stefania Manfrida; Giovanna Mantini; Alessio Albanese; Alba Fiorentino; Vincenzo Frascino; Berardino De Bari; Francesco Micciche'; Fiorenza De Rose; Alessio Giuseppe Morganti; Carmelo Anile; Vincenzo Valentini
Journal:  Neuro Oncol       Date:  2011-10-12       Impact factor: 12.300

3.  Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy.

Authors:  Patrick Beauchesne; Valerie Bernier; Charlotte Carnin; Luc Taillandier; Mohamed Djabri; Laurent Martin; Xavier Michel; Jean-Philippe Maire; Toufic Khalil; Christine Kerr; Thierry Gorlia; Roger Stupp; Remy Pedeux
Journal:  Neuro Oncol       Date:  2010-02-11       Impact factor: 12.300

4.  Adaptive doses of irradiation-an approach to a new therapy concept for bladder cancer?

Authors:  Moshe Schaffer; Silke B Schwarz; Ulrike Kulka; Martin Busch; Eckhart Dühmke
Journal:  Radiat Environ Biophys       Date:  2004-09-29       Impact factor: 1.925

5.  Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation.

Authors:  S Vaganay-Juéry; C Muller; E Marangoni; B Abdulkarim; E Deutsch; P Lambin; P Calsou; F Eschwege; B Salles; M Joiner; J Bourhis
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

6.  Three-times daily ultrafractionated radiation therapy, a novel and promising regimen for glioblastoma patients.

Authors:  Patrick Beauchesne
Journal:  Cancers (Basel)       Date:  2013-09-25       Impact factor: 6.639

7.  Using state variables to model the response of tumour cells to radiation and heat: a novel multi-hit-repair approach.

Authors:  Stephan Scheidegger; Hans U Fuchs; Kathrin Zaugg; Stephan Bodis; Rudolf M Füchslin
Journal:  Comput Math Methods Med       Date:  2013-12-16       Impact factor: 2.238

8.  In-vivo Comparison of 18F-FLT uptake, CT Number, Tumor Volume in Evaluation of Repopulation during Radiotherapy for Lung cancer.

Authors:  Xiaoli Zhang; Jinming Yu; Chengming Li; Xindong Sun; Xue Meng
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

9.  Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.

Authors:  Harold W Davis; Subrahmanya D Vallabhapurapu; Zhengtao Chu; Michael A Wyder; Kenneth D Greis; Venette Fannin; Ying Sun; Pankaj B Desai; Koon Y Pak; Brian D Gray; Xiaoyang Qi
Journal:  Cells       Date:  2020-08-25       Impact factor: 6.600

10.  Pulsed reduced dose-rate radiotherapy for previously irradiated tumors in the brain and spine.

Authors:  Arpan V Prabhu; Madison Lee; Edvaldo Galhardo; Madison Newkirk; Analiz Rodriguez; Fen Xia
Journal:  Surg Neurol Int       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.